Effect of Gem RIS (gemcitabine-releasing intravesical system, TAR-200) on antitumor activity in muscle-invasive bladder cancer (MIBC)

被引：13
|
作者：
Daneshmand, Siamak
Pohar, Kamal S.
Steinberg, Gary D.
Aron, Manju
Cutie, Christopher
机构：
[1] Univ So Calif, Inst Urol, Los Angeles, CA USA
[2] Ohio State Univ, Columbus, OH 43210 USA
[3] Univ Chicago, Urol Sect, Dept Surg, Pritzker Sch Med, Chicago, IL USA
[4] Univ So Calif, Los Angeles, CA USA
[5] TARIS Biomed, Lexington, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e16000
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16000
引用
收藏
页数：6
相关论文
共 50 条
  • [1] The safety, tolerability, and efficacy of a neoadjuvant gemcitabine intravesical drug delivery system (TAR-200) in muscle-invasive bladder cancer patients: a phase I trial
    Daneshmand, Siamak
    Brummelhuis, Iris S. G.
    Pohar, Kamal S.
    Steinberg, Gary D.
    Aron, Manju
    Cutie, Christopher J.
    Keegan, Kirk A.
    Maffeo, John C.
    Reynolds, Donald L.
    Raybold, Bradley
    Chau, Albert
    Witjes, J. Alfred
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (07) : 344.e1 - 344.e9
  • [2] Novel intravesical gemcitabine delivery system (TAR-200) for neoadjuvant treatment of MIBC: context is everything
    Katherine M. Rodriguez
    Max Kates
    Nature Reviews Urology, 2022, 19 : 579 - 580
  • [3] Novel intravesical gemcitabine delivery system (TAR-200) for neoadjuvant treatment of MIBC: context is everything
    Rodriguez, Katherine M.
    Kates, Max
    NATURE REVIEWS UROLOGY, 2022, 19 (10) : 579 - 580
  • [4] Intravesical Gemcitabine Delivery System for muscle-invasive Bladder Cancer
    Lorenz, Judith
    AKTUELLE UROLOGIE, 2023, 54 (06) : 433 - 433
  • [5] TAR-200: Investigational intravesical drug delivery system for bladder cancer
    Munavvir, Muhammed
    Mujeeburahiman, M.
    Khan, Altaf
    Das Debashish, Gaurav
    UROLOGIA JOURNAL, 2025,
  • [6] Intravesical Gemcitabine Delivery System for muscle-invasive Bladder Cancer Comment
    Kalogirou, Charis
    AKTUELLE UROLOGIE, 2023, 54 (06) : 434 - 434
  • [7] The Safety, Tolerability, and Preliminary Efficacy of a Gemcitabine-releasing Intravesical System (TAR-200) in American Urological Association-defined Intermediate-risk Non-muscle-invasive Bladder Cancer Patients: A Phase 1b Study
    van Valenberg, F. Johannes P.
    van der Heijden, Antoine G.
    Cutie, Christopher J.
    Bhanvadia, Sumeet
    Keegan, Kirk A.
    Hampras, Shalaka
    Sweiti, Hussein
    Maffeo, John C.
    Jin, Shu
    Chau, Albert
    Reynolds, Donald L.
    Iarossi, Crysti
    Kelley, April
    Li, Xiang
    Stromberg, Katharine A.
    Sedelaar, J. P. Michiel
    Steenbruggen, Jessica J. O.
    Somford, Diederik M.
    Witjes, J. Alfred
    EUROPEAN JOURNAL OF OPERATIONAL RESEARCH, 2024, 62 (01) : 8 - 15
  • [8] SunRISe-3: TAR-200 plus cetrelimab or TAR-200 versus intravesical Bacillus Calmette-Guerin in patients with BCG-naive high-risk non-muscle-invasive bladder cancer
    Catto, J. W. F.
    Necchi, A.
    Powles, T.
    Guerrero-Ramos, F.
    Simone, G.
    Shore, N.
    Salinas, J. S.
    Merseburger, A. S.
    Roumiguie, M.
    Hiroshi, K.
    Morris, D. M.
    Qiang, W.
    Korkes, F.
    Hasan, M.
    Jin, S.
    Maffeo, J.
    Hammond, C.
    Sweiti, H.
    Somer, R. S.
    Chang, S. S.
    EUROPEAN UROLOGY, 2024, 85 : S1505 - S1505
  • [9] SunRISe-4: TAR-200 plus cetrelimab or cetrelimab alone as neoadjuvant therapy in patients with muscle-invasive bladder cancer (MIBC) who are ineligible for or refuse neoadjuvant platinum-based chemotherapy.
    Psutka, Sarah P.
    Cutie, Christopher
    Bhanvadia, Sumeet Kaur
    Keegan, Kirk A.
    Crist, Wendy
    Tian, Shaozhou Ken
    Maffeo, John
    Raybold, Bradley
    Kashmer, Marietta
    Hasan, Mohamad
    Li, Xiang
    Beeharry, Neil
    Thomas, Shibu
    Tian, Hui
    Powles, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [10] Neoadjuvant chemotherapy (NAC) with dose-dense gemcitabine/cisplatin (DDGC) in localized muscle-invasive bladder cancer (MIBC).
    Tsironis, George
    Zakopoulou, Roubini
    Koutsoukos, Konstantinos
    Tzanis, Kimon
    Varkarakis, John
    Papatsoris, Athanasios
    Stravodimos, Kostas
    Kostouros, Efthymios
    Fragkoulis, Charalampos
    Choreftaki, Theodosia
    Filippiadis, Dimitrios
    Fontara, Sofia
    Dellis, Athanasios
    Ntai, Sparti
    Zygogianni, Anna
    Ntoumas, Konstantinos
    Constantinides, Constantinos A.
    Korkolopoulou, Penelope
    Dimopoulos, Meletios A.
    Bamias, Aristotelis
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345